Oral Apixaban Safe for Thromboprophylaxis Before Surgery in Gynecologic Cancers
Thromboprophylaxis with oral apixaban was similar to subcutaneous enoxaparin with regard to safety outcomes in women undergoing surgery for suspected gynecologic malignancies. (Source: CancerNetwork)
Source: CancerNetwork - March 17, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Cancer Complications Gynecologic Cancers News Conferences/SGO 2017 Source Type: news
Lovenox (Enoxaparin Sodium Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news
Enoxaparin preferred option for VTE prevention after THR in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 31, 2016 Category: Drugs & Pharmacology Source Type: news
Betrixaban in Acutely Ill Bests Enoxaparin Against Strokes: APEX Betrixaban in Acutely Ill Bests Enoxaparin Against Strokes: APEX
The finding in patients hospitalized for acute illness was said to be"a wake-up message" that even those admitted for ischemic stroke or heart failure are at special risk for thrombosis."Heartwire from Medscape (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 29, 2016 Category: Intensive Care Tags: Cardiology News Source Type: news
ENSURE-AF Trial Supports Edoxaban for Electrical Cardioversion
ROME — Results of the largest-ever randomized clinical trial of anticoagulation for electrical cardioversion of patients with nonvalvular atrial fibrillation demonstrate that edoxaban is a safe, effective, and convenient alternative to the standard strategy of enoxaparin as a bridge to warfarin. (Source: Caring for the Ages)
Source: Caring for the Ages - September 29, 2016 Category: Health Management Authors: Bruce Jancin Source Type: news
Blood Clots, Deep Vein Thrombosis and Pulmonary Embolism
What is Deep Vein Thrombosis (DVT)?
DVT is the formation of a blood clot (thrombus) within a deep vein. The deep veins pass through deep tissues and muscles. Muscle contractions (walking, running, activity, etc.) squeeze blood through the deep veins to the heart. The deep veins have valves which prevent blood from flowing back to the ankles and feet.
The majority of blood clots are small and are usually broken down or dissolved. Large clots may form and can block the vein causing the patient to complain of pain and swelling. Homan's sign is not very specific. High index of suspicion is necessary for diagnosis.
Virchow'...
Source: Healthy Living - The Huffington Post - August 17, 2016 Category: Consumer Health News Source Type: news
No significant difference in the risk of Acute Coronary Syndrome (including Myocardial Infarction) seen with Pradaxa < sup > ® < /sup > (dabigatran etexilate) compared to enoxaparin for VTE prevention after orthopaedic surgery
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news
Enoxaparin Adjustment Curbs Thromboembolism in Trauma Patients Enoxaparin Adjustment Curbs Thromboembolism in Trauma Patients
In trauma patients, compared to use of standard prophylactic doses of enoxaparin sodium, dosage adjustment prompted by anti-factor Xa (anti-Xa) trough levels may reduce venous thromboembolism (VTE), according to California-based researchers. < br / > < i > Reuters Health Information < /i > (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 15, 2016 Category: Surgery Tags: Emergency Medicine News Source Type: news
Enoxaparin Adjustment Curbs Thromboembolism in Trauma PatientsEnoxaparin Adjustment Curbs Thromboembolism in Trauma Patients
In trauma patients, compared to use of standard prophylactic doses of enoxaparin sodium, dosage adjustment prompted by anti-factor Xa (anti-Xa) trough levels may reduce venous thromboembolism (VTE), according to California-based researchers. Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 15, 2016 Category: Surgery Tags: Emergency Medicine News Source Type: news
Medical errors and the law
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 7, 2016 Category: Neurology Source Type: news
Medical errors and the law
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Pediatric News)
Source: Pediatric News - July 7, 2016 Category: Journals (General) Source Type: news
Medical errors and the law
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 7, 2016 Category: Endocrinology Source Type: news
Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Family Practice News)
Source: Family Practice News - July 7, 2016 Category: Primary Care Source Type: news
Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 7, 2016 Category: Neurology Source Type: news
Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Pediatric News)
Source: Pediatric News - July 7, 2016 Category: Journals (General) Source Type: news
